Old Web
English
Sign In
Acemap
>
authorDetail
>
Johannes Ettl
Johannes Ettl
Ludwig Maximilian University of Munich
General surgery
Medicine
Talazoparib
Internal medicine
HER2 negative
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
CLO20-052: Hospitalization and Supportive Care Medication (SCM) Utilization Among Patients Treated With Talazoparib (TALA) Monotherapy: An Integrated Analysis of Five Clinical Trials (Phase 1-3) in Advanced Cancers
2020
Journal of The National Comprehensive Cancer Network
Lida A. Mina
Ruben G.W. Quek
Johannes Ettl
Ying Chen
Miguel Martin
Zev A. Wainberg
Johann S. de Bono
Sara A. Hurvitz
Hope S. Rugo
Show All
Source
Cite
Save
Citations (0)
CLO20-039: Patient (pt)-Reported Outcomes (PRO) in Patients With HER2-Negative Locally Advanced/Metastatic Breast Cancer (LA/mBC) and a Germline BRCA1/2 Mutation (gBRCA1/2 mut) Receiving Talazoparib vs. Physician’s Choice of Chemotherapy (PCT): A Focus on EMBRACA Racial Subgroups
2020
Journal of The National Comprehensive Cancer Network
Sara A. Hurvitz
Ruben G.W. Quek
Helen Bhattacharyya
Johannes Ettl
Anthony Gonçalves
Hope S. Rugo
Show All
Source
Cite
Save
Citations (0)
1